Some of the most common illnesses health systems face like heart disease or cancer can be managed, caught or outright prevented if a provider has the proper insights into a patient’s genome. This is ...
Ten years after acquiring deCODE Genetics, Amgen’s collaboration with the Icelandic genetic sleuths has only blossomed, expanding from drug discovery to clinical development. The partners celebrated ...
Long after his death, Hans Jonathan is something of a celebrity in Iceland, where he is thought to have been the first black person. But in Denmark, his extraordinary story is widely ignored. By ...
REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...
REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the ...
Scientists at deCODE genetics, a subsidiary of Amgen, have been focusing on actionable genotypes detected in the Icelandic population. Recently, the researchers found that approximately 1 in 25 ...
Scientists at deCODE genetics, a subsidiary of Amgen, have published a study in Nature Communications, comparing over 110 thousand patients with autoimmune thyroid disease (AITD) from Iceland, Finland ...
SALT LAKE CITY, Oct. 20, 2021 /PRNewswire/ -- Scientists in the United States and Iceland who are collecting and studying DNA as part of the HerediGene: Population Study, the world's largest DNA ...
REYKJAVIK, Iceland, June 24, 2020 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system, University of Iceland and the ...
deCODE has significant operations in Iceland and pays a large proportion of its fixed costs in Icelandic krona, while its sales are generally denominated in US dollars and its reporting currency is ...
What began as discussions around a scientific collaboration a few months ago blossomed into a full acquisition deal between Amgen Inc., of Thousand Oaks, Calif., and DeCode Genetics, of Reykjavik, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results